ArticleCurrent medical imaging2026
Intrahepatic Splenosis Mimicking Hepatocellular Carcinoma: A Case Series of Eleven Patients.
Article in Current medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIntrahepatic splenosis is an extremely rare intrahepatic mass, which is easily misdiagnosed and mistreated. There are a few reports in the literature that intrahepatic splenosis mimicking hepatocellular carcinoma in a patient with elevated AFP. This study aims to analyze the diagnosis and treatment strategies of intrahepatic splenosis. MATERIALS AND
methodsThe clinical data of eleven patients with intrahepatic splenosis, diagnosed and treated at Wuhan Asia General Hospital and Union Hospital (Wuhan, China) between March 2012 and November 2024, were retrospectively analyzed. Enhanced CT imaging and enhanced MRI were used for the screening and diagnosis of liver lesions.
resultsOf the eleven patients with intrahepatic splenosis, six cases were pure intrahepatic splenosis, and five cases included extrahepatic splenosis. Enhanced CT imaging or enhanced MRI showed intrahepatic splenosis lesions with uneven enhancement in the form of fast in and fast out. Two patients were misdiagnosed with hepatocellular carcinoma due to elevated AFP, but biopsy revealed intrahepatic splenosis, thus avoiding unnecessary resection. The size of the intrahepatic splenosis lesions ranged from 1.0 to 4.2 cm. None of the nine patients who underwent surgical resection had splenosis recurrences, and the patients with intrahepatic splenosis confirmed by liver biopsy did not show lesion progression during the active examination period. DISCUSSION: Splenosis refers to the autotransplantation of viable splenic tissue into different anatomic compartments following splenic injury. The enhanced CT or MRI features of intrahepatic splenosis are similar to those of HCC. Selective hepatic arteriography may help differentiate intrahepatic splenosis from HCC. Percutaneous liver biopsy helps diagnose intrahepatic splenosis.
conclusionIn patients who have previously undergone splenectomy due to splenic trauma, it is important to consider the potential occurrence of intrahepatic splenosis upon the identification of intrahepatic lesions, and percutaneous liver biopsy is recommended. For individuals without clinical symptoms following a confirmed diagnosis of intrahepatic splenosis, no specific treatment is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.